-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $16

Benzinga·11/19/2025 18:00:21
Listen to the news
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $17 to $16.